For the present paralleled , randomized , triple-blinded , placebo-controlled clinical trial , 40 type 2 diabetes patients aged 25-50 yr old and on stable medication were recruited from the Iranian Diabetes Society and endocrinology clinics in East Azarbayjan ( Tabriz , Iran ) and randomly assigned into two groups .